Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Siolta Therapeutics

Siolta Therapeutics

Siolta Therapeutics develops microbiome analyses to test microbial-based therapeutics for the treatment and prevention of inflammatory diseases. The company was founded in 2016 by Nikole Kimes PhD.

All edits by  Sameeha Sulaiman 

Edits on 18 Feb, 2019
Sameeha Sulaiman
Sameeha Sulaiman edited on 18 Feb, 2019
Edits made to:
Article (+543/-316 characters)
Table (+6 rows) (+12 cells) (+204/-6 characters)
Article

Co-founded in late 2016 by Susan Lynch, Nikole Kimes, and Samir Kaul. Siolta Therapeutics is conducting scientific research aimed at the prevention and treatment of inflammatory diseases, including airway inflammation like Asthma, by using the human microbiome.

Siolta Therapeutics. 97 likes · 7 were here. Siolta Therapeutics is a privately held, venture-backed biotech company focusedbased in San Francisco. It focuses on developing therapeutic microbial consortia to prevent... and treat inflammatory diseases.

The company's lead product candidate is a therapeutic developed from gut microbiome for the prevention and treatment of allergic asthma. The product is also being explored for the treatment of other allergic conditions such as seasonal allergy, food allergy, and atopic dermatitis. Phase 1 clinical trials are ongoing for these target conditions. Future plans also include the development of therapeutics for other chronic inflammatory diseases.

Table

Name
Role
Related Golden topics

Benjamin M. Fieberger

Scientist

Homer Boushey

Medical Advisor

Jill Bilodeaux

Research Technician

Neeraja Vajrala

Senior Scientist

Nikole Kimes

Co-founder and& CSOChief Scientific Officer

UCSF

Sameeha Sulaiman
Sameeha Sulaiman edited on 18 Feb, 2019
Edits made to:
Infobox (+4/-4 properties)
Article (+153 characters)
Article

Siolta Therapeutics. 97 likes · 7 were here. Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent...

Infobox
Golden logo
By using this site, you agree to our Terms & Conditions.